Chu S et al., 2026-09: Neuroblastoma and cervical carcinoma cell study reporting that ivermectin delays stress-granule disassembly by blocking de novo Hsp70 synthesis, adding a proteostasis mechanism alongside its nuclear-transport effects.
The anti-parasitic drug ivermectin inhibits nuclear trafficking and has potential anti-cancer activities. However, the molecular pathways that promote ivermectin's therapeutic actions are poorly understood.
n/a (HTML full text)
Chu S et al., 2026-09: Neuroblastoma and cervical carcinoma cell study reporting that ivermectin delays stress-granule disassembly by blocking de novo Hsp70 synthesis, adding a proteostasis mechanism alongside its nuclear-transport effects. Study type: human neuroblastoma and cervical carcinoma cell lines, in vitro. N: n/a. Country: Canada (McGill University, Montreal). Dose: not stated in the abstract. Declared COI: 'The authors declare no conflicts of interest.' Comparator: untreated stressed cells. Adds Hsp70 to the 'other targets' list in C8. Study type: lab.
